T cell receptor-mimicking humanized monoclonal RL21A antibodies (PhosImmune/Pure MHC)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameT cell receptor-mimicking humanized monoclonal RL21A antibodies (PhosImmune/Pure MHC)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionT-cell receptor agonistsHuman leukocyte antigen inhibitors
TargetsT-cell receptorHuman leukocyte antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPure Mhc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgenus IncPhosImmune IncPure Mhc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A